Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAT | AMGN | BMY | VRTX | GILD |
| Company | Phathom Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 9.02 | 290.84 | 58.35 | 454.30 | 89.81 |
| High | 9.98 | 292.81 | 58.78 | 457.54 | 90.31 |
| Low | 8.95 | 288.78 | 57.62 | 449.04 | 89.27 |
| Last | 9.56 | 293.51 | 58.64 | 452.38 | 89.79 |
| Change | +0.11 | +3.61 | +0.41 | +2.01 | +0.03 |
| % Change | +1.16% | +1.25% | +0.70% | +0.45% | +0.03% |
| Volume | 497,500 | 511,676 | 1,985,723 | 335,469 | 836,903 |
| 20-Day Average Volume | 1,889,027 | 2,864,254 | 12,132,218 | 1,309,522 | 7,279,979 |
| Previous Close | 9.45 | 289.90 | 58.23 | 450.37 | 89.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.72 | 306.16 | 56.26 | 477.84 | 90.93 |
| 20-Day Raw Stochastic | 10.00% | 30.84% | 73.62% | 6.40% | 29.33% |
| 20-Day Relative Strength | 34.20% | 38.05% | 61.63% | 40.72% | 53.76% |
| Weighted Alpha | +56.57 | +2.84 | +27.25 | +17.85 | +26.22 |
| Today's Opinion | 24% Sell | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Previous Opinion | 24% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 40% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.28% since 11/15/24 | +2.89% since 11/15/24 | +4.30% since 11/15/24 | -3.42% since 11/15/24 | +1.63% since 11/15/24 |
| Low | 8.49 on 11/18/24 | 275.56 on 11/19/24 | 55.84 on 11/18/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 9.98 on 11/22/24 | 292.50 on 11/22/24 | 58.83 on 11/20/24 | 468.88 on 11/18/24 | 90.31 on 11/22/24 |
| 1-Month | |||||
| %Chg | -42.16% since 10/22/24 | -8.71% since 10/22/24 | +11.14% since 10/22/24 | -5.29% since 10/22/24 | +1.91% since 10/22/24 |
| Low | 8.49 on 11/18/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 19.50 on 11/04/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -25.10% since 08/22/24 | -10.08% since 08/22/24 | +23.13% since 08/22/24 | -6.27% since 08/22/24 | +18.37% since 08/22/24 |
| Low | 8.49 on 11/18/24 | 275.56 on 11/19/24 | 47.38 on 08/23/24 | 445.00 on 11/21/24 | 75.91 on 08/23/24 |
| High | 19.71 on 09/19/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -7.29% since 05/22/24 | -5.69% since 05/22/24 | +38.49% since 05/22/24 | +0.50% since 05/22/24 | +32.51% since 05/22/24 |
| Low | 8.49 on 11/18/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 19.71 on 09/19/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 646,163 | 155,830,816 | 118,100,752 | 115,983,328 | 111,864,840 |
| Shares Outstanding, K | 68,377 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 680,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -201,590,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 16,350,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -85,580,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.72 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.32 on 11/07/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/07/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.98 | 49.47 | 0.00 | 20.01 |